Alto Neuroscience Inc. (ANRO) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Alto Neuroscience Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$23.33
+0.60% today
Market cap
$910M
Overall quality
42/100
Kronos AI 30-day
+4.3%
6 of 8 simulated paths end higher
Alto Neuroscience Inc. (ANRO) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $910M. It trades at $23.33, up 0.60% today. Its overall quality score is 42 out of 100, ranked against the whole US market. 5 analysts' average target of $45.67 implies +95.8% from today's price. Kronos AI's 30-day forecast is +4.3% (6 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $45.67 |
| Low – high | $37.00 – $60.00 |
| Analysts | 5 |
| Upside to average | +95.8% |
Kronos AI 30-day forecast
| Expected close | $24.18 (+4.3%) |
| Likely range | −2.6% … +10.0% |
| As of | 2026-10-27 |
6 of 8 simulated paths end higher.
Quality scores
| Profitability | 40 |
| Solvency | 54 |
| Growth | 32 |
| Overall | 42 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.